Veterinary raw materials
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
Pharmaceutical
OEM & ODM
Phone: 86-29-89601602
E-mail: sales28@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Pharmaceutical Sulfamethoxazole Raw Materials Powder CAS 723-46-6 API Factory Supply
Product Overview:
Sulfamethoxazole drugs have a broader antibacterial spectrum, with some inhibitory effect on most Gram-positive and negative bacteria, but their antibacterial potency varies among different sulfonamide drugs. With the wide application of sulfonamides, they will also be prone to the formation of drug-resistant strains, especially Staphylococcus aureus has more chances to produce drug resistance. According to the absorption after oral administration, sulfonamides can be classified into two categories, the first category is easily absorbed sulfonamides, which is characterised by fast absorption, generally in the drug after 2-4h (long-acting drugs in 5h) blood concentration can reach the peak, this type of sulfonamides are mainly used for systemic infections. The other type is not easily absorbed or absorbed very little after oral administration, and most of them are excreted through the intestinal tract, mainly used for intestinal infections.
Sulfamethoxazole is a broad-spectrum antimicrobial drug with particularly strong effects on staphylococci and Escherichia coli, and is used in the treatment of urinary tract infections as well as avian cholera, etc. Sulfamethoxazole is a broad-spectrum antimicrobial drug with high blood concentration.
Sulfamethoxazole is a systemically applied intermediate-acting sulfonamides, which can competitively act with PABA on dihydrofolate synthase in bacteria, preventing the synthesis of bacterial dihydrofolate and thus inhibiting bacterial growth and reproduction. With sulfadiazine, sulfisoxazole, trisulfadiazine three sulfonamides are currently the better drugs for the treatment of nocardiosis. Half-life of 10 ~ 12 hours, can be partially acetylated. The number of times this product needs to be used is less than sulfisoxazole (2 times a day instead of 4 times a day), but its acetylated metabolites are less soluble in the urine, so the possibility of crystalluria is slightly greater, the patient should be kept fully hydrated (adult daily urine output of not less than 1,500 ml). When combined with the synergist methotrexate, the antimicrobial effect is markedly enhanced, and cotrimoxazole (sulphamethoxazole/metronidazole i.e. SMZ/TMP) is often preferable to monotherapy (see Dihydrofolate Reductase Inhibitors). It is commonly used clinically for the treatment of urinary tract infections, respiratory tract infections, typhoid fever, and Salmonella infections, Pneumocystis carinii, and nocardiosis, as well as for the prevention of epidemic meningitis.
Pharmaceutical Sulfamethoxazole Raw Materials Powder CAS 723-46-6 API Factory Supply Attributes
CAS:723-46-6
MF: C10H11N3O3S
MW: 253.28
EINECS: 211-963-3
Specification: 99% min Sulfamethoxazole Powder
Sample: Sulfamethoxazole Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Pharmaceutical Sulfamethoxazole Raw Materials Powder CAS 723-46-6 API Factory Supply Details
Sulfamethoxazole Powder Usage and Synthesis.
We know that bacterial synthesis of thymidine, purine and ultimately DNA requires the folate derivative tetrahydrofolate as its cofactor. Most bacterial cells are not permeable to folic acid and must synthesise it with para-aminobenzoic acid (PABA). Sulfonamides, which are structurally similar to PABA, competitively inhibit the synthesis of dihy-dropteroic acid, the direct precursor of dihydrofolate, from PABA and pteridine. Mammalian cells, on the other hand, are not inhibited because they require preformed folic acid and cannot synthesise this. Therapeutic concentrations of the sulfonamide sulfamethoxazole are primarily bacteriostatic, but exposure to sulfonamides can produce a bactericidal effect, "thymine-deficient lethality", when bacteria are grown in substrates containing purines and amino acids and very low concentrations of thymine.
This bactericidal effect has been demonstrated in human blood and urine (Then and Angehrn, 1973A and B; see also Pratt and Fekety, 1986). Sulfonamide-induced inhibition of mycobacterial cell growth can be reversed if certain substances (e.g., thymidine, purine, methionine, serine) are added to the growth matrix in vitro. This situation may be clinically important because the pus produced by cell destruction may contain many of these substances, so that drug action may be inhibited in purulent infections by the presence of such substances. Furthermore, PABA should not be present in the culture medium for in vitro drug sensitivity testing, as even trace amounts may interfere with the results.
Uses and functions of Sulfamethoxazole Powder.
Sulfamethoxazole is used as an antimicrobial agent and is particularly effective against staphylococci and E. coli. It is mainly used for the treatment of avian cholera, etc.
Anti-infectives, used for urinary tract infections, respiratory tract infections, intestinal infections, Salmonella spp. infections, paediatric acute otitis media, prevention of rheumatoid arthritis
Sulfamethoxazole is mainly used for the treatment of acute and chronic urinary tract infections, but also for the prevention of meningitis and acute otitis media caused by influenza bacteria, etc.
Sulfamethoxazole can inhibit the growth of bacteria, especially strong effect on staphylococcus and E. coli, good effect in treating urinary tract infection and poultry mess.
Sulfamethoxazole is white crystalline powder; odourless, slightly bitter taste. It is almost insoluble in water, but soluble in dilute hydrochloric acid, sodium hydroxide test solution or ammonia test solution. The melting point of the product is 168～172℃.
Sulfamethoxazole is white crystalline powder; odourless, slightly bitter taste. The product is almost insoluble in water, soluble in dilute hydrochloric acid, sodium hydroxide test solution or ammonia test solution. Melting point The melting point of this product is 168～172℃.
Sulfonamide antibiotic, inhibits enzyme dihydropteroate synthase (enzyme dihydropteroate synthase), thus blocking the synthesis of dihydrofolate.
Pharmacological Effects of Sulfamethoxazole Powder.
Sulfamethoxazole is a systemically applied intermediate-acting sulfonamide, which is a broad-spectrum bacteriostatic agent. Its antibacterial mechanism of action is due to its structural similarity to p-aminobenzoic acid (PABA), which can compete with PABA to act on the dihydrofolate synthase in bacteria, preventing the synthesis of bacterial dihydrofolate and thus inhibiting the growth and reproduction of bacteria. Sulfamethoxazole has antibacterial activity against both Gram-positive and negative bacteria, but bacterial resistance to this class of drugs is now widespread, with an increase in drug-resistant strains of staphylococcus spp, gonococcus spp, meningococcus spp, and enterobacteria spp bacteria. In addition, sulfamethoxazole is also active in vitro against microorganisms such as Chlamydia trachomatis, Nocardia asteroides, Plasmodium falciparum and Toxoplasma gondii.
Production method of Sulfamethoxazole Powder.
Taking 5-methylisoxazole-3-carboxamide as raw material, it was degraded to 5-methylisoxazole-3-amine under the action of sodium hypochlorite, and then condensed with p-acetamidobenzenesulfonyl chloride to form 3-(p-acetamidobenzenesulfonamidato)-5-methylisoxazole, and then hydrolysed under alkaline condition to obtain 3-(p-aminobenzenesulfonamido)-5-methylisoxazole.
